Product Information
ATAZANAVIR SULFATE 200 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.0904 per EA under NDC 00093552706. Its NADAC has been published 236 times since Mar 21, 2018.
Strength
200 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093552706
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATAZANAVIR SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA091673On Market Since
12/27/2017
Pharmacological Classes
Price Statistics
The NADAC for ATAZANAVIR SULFATE 200 MG CAP has been published 236 times since Mar 21, 2018, and over the history we have for it it has declined 92.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0904 per EA |
|---|---|
| All-time high | $14.7312 (Mar 13, 2019) |
| All-time low | $1.0536 (May 20, 2026) |
| 52-week high | $1.6664 |
| 52-week low | $1.0536 |
| Median price | $4.2472 |
| Average price | $5.7083 |
| Largest weekly change | -66.0% (Mar 20, 2019) |
| Weeks tracked | 236 |
| Tracking since | Mar 21, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Atazanavir Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ATAZANAVIR SULFATE 200 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ATAZANAVIR SULFATE 200 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $1.0904 per EA (NDC 00093552706), effective Jun 24, 2026.
How has the price of ATAZANAVIR SULFATE 200 MG CAP changed over time?
Over the history we have for it, the NADAC for ATAZANAVIR SULFATE 200 MG CAP has declined 92.6%. It has been tracked across 236 weekly CMS publications since Mar 21, 2018.
What are the highest and lowest recorded NADAC prices for ATAZANAVIR SULFATE 200 MG CAP?
Since Mar 21, 2018, the NADAC for ATAZANAVIR SULFATE 200 MG CAP has ranged from a low of $1.0536 (May 20, 2026) to a high of $14.7312 (Mar 13, 2019), with a median of $4.2472 per EA.
Are there cheaper alternatives to ATAZANAVIR SULFATE 200 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ATAZANAVIR SULFATE 200 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures ATAZANAVIR SULFATE 200 MG CAP?
ATAZANAVIR SULFATE 200 MG CAP (NDC 00093552706) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification